HomeBIOTECHNOLOGY
BIOTECHNOLOGY
Medical Device News Magazine reports breaking biotechnology news in addition to medical device news.
Oxford Nanopore Technologies and Fabric Genomics Collaborate to Launch an Integrated Whole-Genome Sequencing Solution to Advance the Future of Paediatric Patient Care
"For this incredibly high-risk patient population, speed and data-rich insights matter,” said Gordon Sanghera, PhD, CEO of Oxford Nanopore Technologies. “We are excited to team up with Fabric Genomics to develop an end-to-end analysis tool for the clinical reporting of nanopore sequencing data in paediatric care settings that will make it easier for healthcare providers to leverage genetic insights and, in the future, support the health and wellbeing of children and families.”
Frontier Bio Leads Medical Innovation with “Lab-Grown” Blood Vessel Technology for Replacing Animal Testing
By introducing lab-grown vessels, Frontier Bio is championing a future where reliance on such animal testing is significantly reduced, if not eliminated.
Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care
The two assays are the collaborative effort of Mindray and HyTest, a Mindray company and a prominent global provider of antibodies and antigens. HyTest, renowned for its cardiac biomarker expertise, had its cardiac troponin complex material selected as the international troponin standard by AACC in 2004.
SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
SOPHIA GENETICS notes the three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science.
BrainStorm Cell Therapeutics to Meet with US FDA to Discuss Development Plan for NurOwn as a Treatment of ALS
Brainstorm Therapeutics notes the path forward for ALS is a registrational Phase 3b U.S. clinical trial
Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies
Be The Match BioTherapies®, an organization offering solutions for companies developing and commercializing cell and gene therapies, and Cryoport (NASDAQ: CYRX), a leading global provider of innovative products and services to the fast-growing cell & gene therapy industry enabling the future of medicine for a new era of life sciences, today announced a new strategic partnership.
Readygo Diagnostics Initiates An Assay Development Contract With Gemina Laboratories For The Detection Of Dengue From Saliva Samples
ReadyGo Diagnostics will develop, optimize and validate an assay for the detection of the dengue virus (DENV) for Gemina to run on ReadyGo’s off-grid isothermal diagnostic platform, Geo. The Geo platform provides rapid results in any location in under 30 minutes and is expected to play a crucial role in the detection of DENV within near-patient settings which would greatly improve patient management and outcome.
Newly Published Data Supports Effectiveness of BIOTRONIK Neuro’s RESONANCE ™ Stimulation
"As we await additional data from our BENEFIT-03 study, we're excited to see these initial data on the long-term effects of our SCS system," said BIOTRONIK Neuro President Todd Langevin. "We developed Prospera to offer patients sustainable pain relief – and we believe its proactive care model will have a clinically meaningful impact on lowering long-term failure rates and reducing the service burden of SCS."
Principles and Applications of Amplicon Sequencing
Amplicon sequencing is a type of DNA sequencing technique commonly used to analyze a specific genetic region. This technique involves the amplification of a DNA fragment, or amplicon, using techniques such as PCR (polymerase chain reaction) to generate a large number of copies. Once these copies are made, they are sequenced to identify genetic variations or mutations. Amplicon sequencing is often used in research and clinical settings due to its high sensitivity and capability to analyze multiple specific regions simultaneously.
